Seelos therapeutics to participate in the b. riley securities' virtual neuro and ophthalmology conference

New york , april 22, 2022 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the b. riley securities' virtual neuro and ophthalmology conference, april 27-28, 2022.
SEEL Ratings Summary
SEEL Quant Ranking